Cargando…

Pheochromocytoma in Congenital Cyanotic Heart Disease

Studies on genome-wide transcription patterns have shown that many genetic alterations implicated in pheochromocytoma-paraganglioma (P-PGL) syndromes cluster in a common cellular pathway leading to aberrant activation of molecular response to hypoxia in normoxic conditions (the pseudohypoxia hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Aresta, Carmen, Butera, Gianfranco, Tufano, Antonietta, Grassi, Giorgia, Luzi, Livio, Benedini, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176301/
https://www.ncbi.nlm.nih.gov/pubmed/30356369
http://dx.doi.org/10.1155/2018/2091257
_version_ 1783361674211753984
author Aresta, Carmen
Butera, Gianfranco
Tufano, Antonietta
Grassi, Giorgia
Luzi, Livio
Benedini, Stefano
author_facet Aresta, Carmen
Butera, Gianfranco
Tufano, Antonietta
Grassi, Giorgia
Luzi, Livio
Benedini, Stefano
author_sort Aresta, Carmen
collection PubMed
description Studies on genome-wide transcription patterns have shown that many genetic alterations implicated in pheochromocytoma-paraganglioma (P-PGL) syndromes cluster in a common cellular pathway leading to aberrant activation of molecular response to hypoxia in normoxic conditions (the pseudohypoxia hypothesis). Several cases of P-PGL have been reported in patients with cyanotic congenital heart disease (CCHD). Patients affected with CCHD have an increased likelihood of P-PGL compared to those affected with noncyanotic congenital heart disease. One widely supported hypothesis is that chronic hypoxia represents the determining factor supporting this increased risk. We report the case of a 23-year-old woman affected with congenital tricuspid atresia surgically by the Fontan procedure. The patient was admitted to hospital with hypertensive crisis and dyspnea. Chest computed tomography revealed, incidentally, a 6-cm mass in the left adrenal lodge. Increased levels of noradrenaline (NA) and its metabolites were detected (plasma NA 5003.7 pg/ml, n.v.<480; urinary NA 1059.5 µg/24 h, n.v.<85.5; urinary metanephrine 489 µg/24 h, n.v.<320). The patient did not report any additional symptom related to catecholamine excess. The left adrenal tumor showed abnormal accumulation when 131I-metaiodobenzylguanidine scintigraphy was performed. A 18F-fluorodeoxyglucose positron emission tomography showed no significant metabolic activity in the left adrenal gland but intense uptake in the supra- and subdiaphragmatic brown adipose tissue, probably due to noradrenergic-stimulated glucose uptake. The patient underwent left open adrenalectomy after preconditioning with α- and β-blockers and histopathological examination confirmed the diagnosis of pheochromocytoma (Ki-67<5%). Screening for germline mutations did not show any genes mutation (investigated mutations: RET, TMEM127, MAX, SDHD, SDHC, SDHB, SDHAF2, SDHA, and VHL). Clinicians should consider P-PGL when an unexplained clinical deterioration occurs in CCHD patients, even in the absence of typical paroxysmal symptoms.
format Online
Article
Text
id pubmed-6176301
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-61763012018-10-23 Pheochromocytoma in Congenital Cyanotic Heart Disease Aresta, Carmen Butera, Gianfranco Tufano, Antonietta Grassi, Giorgia Luzi, Livio Benedini, Stefano Case Rep Endocrinol Case Report Studies on genome-wide transcription patterns have shown that many genetic alterations implicated in pheochromocytoma-paraganglioma (P-PGL) syndromes cluster in a common cellular pathway leading to aberrant activation of molecular response to hypoxia in normoxic conditions (the pseudohypoxia hypothesis). Several cases of P-PGL have been reported in patients with cyanotic congenital heart disease (CCHD). Patients affected with CCHD have an increased likelihood of P-PGL compared to those affected with noncyanotic congenital heart disease. One widely supported hypothesis is that chronic hypoxia represents the determining factor supporting this increased risk. We report the case of a 23-year-old woman affected with congenital tricuspid atresia surgically by the Fontan procedure. The patient was admitted to hospital with hypertensive crisis and dyspnea. Chest computed tomography revealed, incidentally, a 6-cm mass in the left adrenal lodge. Increased levels of noradrenaline (NA) and its metabolites were detected (plasma NA 5003.7 pg/ml, n.v.<480; urinary NA 1059.5 µg/24 h, n.v.<85.5; urinary metanephrine 489 µg/24 h, n.v.<320). The patient did not report any additional symptom related to catecholamine excess. The left adrenal tumor showed abnormal accumulation when 131I-metaiodobenzylguanidine scintigraphy was performed. A 18F-fluorodeoxyglucose positron emission tomography showed no significant metabolic activity in the left adrenal gland but intense uptake in the supra- and subdiaphragmatic brown adipose tissue, probably due to noradrenergic-stimulated glucose uptake. The patient underwent left open adrenalectomy after preconditioning with α- and β-blockers and histopathological examination confirmed the diagnosis of pheochromocytoma (Ki-67<5%). Screening for germline mutations did not show any genes mutation (investigated mutations: RET, TMEM127, MAX, SDHD, SDHC, SDHB, SDHAF2, SDHA, and VHL). Clinicians should consider P-PGL when an unexplained clinical deterioration occurs in CCHD patients, even in the absence of typical paroxysmal symptoms. Hindawi 2018-09-25 /pmc/articles/PMC6176301/ /pubmed/30356369 http://dx.doi.org/10.1155/2018/2091257 Text en Copyright © 2018 Carmen Aresta et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Aresta, Carmen
Butera, Gianfranco
Tufano, Antonietta
Grassi, Giorgia
Luzi, Livio
Benedini, Stefano
Pheochromocytoma in Congenital Cyanotic Heart Disease
title Pheochromocytoma in Congenital Cyanotic Heart Disease
title_full Pheochromocytoma in Congenital Cyanotic Heart Disease
title_fullStr Pheochromocytoma in Congenital Cyanotic Heart Disease
title_full_unstemmed Pheochromocytoma in Congenital Cyanotic Heart Disease
title_short Pheochromocytoma in Congenital Cyanotic Heart Disease
title_sort pheochromocytoma in congenital cyanotic heart disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176301/
https://www.ncbi.nlm.nih.gov/pubmed/30356369
http://dx.doi.org/10.1155/2018/2091257
work_keys_str_mv AT arestacarmen pheochromocytomaincongenitalcyanoticheartdisease
AT buteragianfranco pheochromocytomaincongenitalcyanoticheartdisease
AT tufanoantonietta pheochromocytomaincongenitalcyanoticheartdisease
AT grassigiorgia pheochromocytomaincongenitalcyanoticheartdisease
AT luzilivio pheochromocytomaincongenitalcyanoticheartdisease
AT benedinistefano pheochromocytomaincongenitalcyanoticheartdisease